Metastatic Head and Neck Cancer

Also known as: Head and Neck Cancer Metastatic / Metastatic Squamous Cell Carcinoma of the Head or Neck / Metastatic Squamous cell carcinoma of head and neck / Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) / Metastatic Squamous Cell Carcinoma of the Head and Neck / Metastatic Head-and-neck Squamous-cell Carcinoma / Metastatic Head and Neck Squamous Cell Carcinoma

DrugDrug NameDrug Description
DB00002CetuximabAn endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck.
DB01248DocetaxelA taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NameTargetType
DB00002CetuximabEpidermal growth factor receptortarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00002CetuximabComplement C1q subcomponent subunit Atarget
DB00002CetuximabComplement C1q subcomponent subunit Btarget
DB00002CetuximabComplement C1q subcomponent subunit Ctarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00002CetuximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB01248DocetaxelApoptosis regulator Bcl-2target
DB01248DocetaxelTubulin beta-1 chaintarget
DB01248DocetaxelCytochrome P450 3A4enzyme
DB01248DocetaxelCytochrome P450 3A5enzyme
DB01248DocetaxelCytochrome P450 3A7enzyme
DB01248DocetaxelP-glycoprotein 1transporter
DB01248DocetaxelMultidrug resistance-associated protein 7transporter
DB01248DocetaxelCytochrome P450 1B1enzyme
DB01248DocetaxelMicrotubule-associated protein 2target
DB01248DocetaxelMicrotubule-associated protein 4target
DB01248DocetaxelMicrotubule-associated protein tautarget
DB01248DocetaxelSolute carrier organic anion transporter family member 1B3transporter
DB01248DocetaxelSolute carrier family 22 member 7transporter
DB01248DocetaxelATP-binding cassette sub-family G member 2transporter
DB01248DocetaxelCanalicular multispecific organic anion transporter 1transporter
DB01248DocetaxelMultidrug resistance-associated protein 1transporter
DB01248DocetaxelNuclear receptor subfamily 1 group I member 2target
DB09035NivolumabProgrammed cell death protein 1target
DB09035NivolumabProgrammed cell death 1 ligand 1target
DB09037PembrolizumabProgrammed cell death protein 1target
DB09037PembrolizumabProgrammed cell death 1 ligand 1target
DrugDrug NamePhaseStatusCount
DB12565Abexinostat1Completed1
DB08916Afatinib1Withdrawn1
DB11595Atezolizumab1Recruiting1
DB00515Cisplatin1Active Not Recruiting1
DB00531Cyclophosphamide1Not Yet Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Not Yet Recruiting1
DB17107Lifileucel1Recruiting1
DB00678Losartan1Recruiting1
DB01204Mitoxantrone1Completed1
DB09035Nivolumab1Withdrawn1
DB01269Panitumumab1Recruiting1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Recruiting3
DB09037Pembrolizumab1Terminated1
DB00020Sargramostim1Recruiting1
DB09143Sonidegib1Recruiting1
DB16409Tiragolumab1Recruiting1
DB12015Alpelisib1 / 2Terminated1
DB14707Cemiplimab1 / 2Active Not Recruiting1
DB00002Cetuximab1 / 2Active Not Recruiting1
DB00002Cetuximab1 / 2Terminated1
DB11714Durvalumab1 / 2Terminated1
DB15631Edodekin alfa1 / 2Active Not Recruiting1
DB15721Natural Killer Cell1 / 2Active Not Recruiting1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB11771Tremelimumab1 / 2Terminated1
DB14722ADU-S1002Terminated1
DB17465CD-16 NK-92 cells2Recruiting1
DB06772Cabazitaxel2Completed1
DB14776Camrelizumab2Recruiting1
DB00958Carboplatin2Active Not Recruiting2
DB00958Carboplatin2Recruiting2
DB14707Cemiplimab2Recruiting1
DB00002Cetuximab2Recruiting2
DB00515Cisplatin2Recruiting1
DB01248Docetaxel2Active Not Recruiting1
DB01248Docetaxel2Recruiting1
DB11952Duvelisib2Active Not Recruiting1
DB11717Epacadostat2Terminated1
DB17508Hafnium oxide2Recruiting1
DB16479Inbakicept2Recruiting1
DB11743Ipatasertib2Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB09035Nivolumab2Completed1
DB09035Nivolumab2Recruiting1
DB09074Olaparib2Active Not Recruiting1
DB17422Ozuriftamab vedotin2Recruiting1
DB01229Paclitaxel2Active Not Recruiting2
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting2
DB09037Pembrolizumab2Recruiting7
DB09037Pembrolizumab2Terminated2
DB05578Ramucirumab2Recruiting1
DB15766Retifanlimab2Withdrawn1
DB14765Rivoceranib2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB00820Tadalafil2Recruiting1
DB14944Tarloxotinib2Terminated1
DB17301Tavokinogene telseplasmid2Terminated1
DB11595Atezolizumab2 / 3Recruiting1
DB15140Bempegaldesleukin2 / 3Terminated1
DB00112Bevacizumab2 / 3Recruiting1
DB00958Carboplatin2 / 3Recruiting1
DB00002Cetuximab2 / 3Recruiting1
DB14547Chloride ion2 / 3Recruiting1
DB00515Cisplatin2 / 3Recruiting1
DB01248Docetaxel2 / 3Recruiting1
DB09037Pembrolizumab2 / 3Terminated1
DB12257Platinum2 / 3Recruiting1
DB00958Carboplatin3Completed1
DB00958Carboplatin3Recruiting1
DB00002Cetuximab3Completed1
DB00002Cetuximab3Recruiting1
DB14547Chloride ion3Recruiting1
DB00515Cisplatin3Completed1
DB00515Cisplatin3Recruiting1
DB01248Docetaxel3Terminated1
DB11680Ficlatuzumab3Recruiting1
DB00544Fluorouracil3Completed1
DB00544Fluorouracil3Recruiting1
DB00317Gefitinib3Terminated1
DB01229Paclitaxel3Recruiting1
DB09037Pembrolizumab3Completed1
DB09037Pembrolizumab3Recruiting1
DB12257Platinum3Recruiting1
DB09037PembrolizumabNot AvailableRecruiting1